HeiQ Viroblock NPJ03 textile treatment proven effective against viral and bacterial infection
Swiss-designed and award-winning HeiQ Viroblock NPJ03 is an antiviral and antibacterial textile treatment that its developers describe as: “A unique combination of silver and vesicle technologies designed to significantly reduce viral and bacterial contamination on treated surfaces, resulting in over 99.9% destruction of viruses in five minutes – including SARS-COV-2 (COVID-19).”
Against strong competition HeiQ won the coveted Swiss Technology Award 2020. It was presented first prize for its breakthrough antiviral textile technology HeiQ Viroblock.
An HeiQ spokesperson explained: “The treatment has had a major impact on the global textile industry and is being adopted by mills around the world. HeiQ Viroblock is one of the world’s most efficient and effective antiviral/antimicrobial technologies which has been applied by more than 150 brands worldwide to over one billion products.
“It has been selected for a broad portfolio of products from face masks for hospital, and community healthcare teams to hospitality linen goods and clothing, to home textiles, mattresses and curtains.”
They continued: “Despite the success of the vaccine roll-outs we are still faced with high rates of healthcare associated infections (HAIs), a transient arena of coronavirus variants, and a surge in respiratory viruses predicted across Europe and the UK this coming winter. Healthcare professionals and regulatory bodies have expressed their concerns and are calling for more effective PPE, not for more stockpiles of current PPE.
“Developed by our pool of scientists in the laboratories at HeiQ headquarters in Zurich, Switzerland, this unique, fully compliant PPE destroys viruses and bacteria on contact. It is amongst the first textile technologies in the world to be proven 99.99% effective against SARS-CoV-2, and it also protects against all influenzas and noroviruses.”
The spokesperson added: “We believe our PPE is some of the safest protection and prevention available anywhere and is currently being distributed in Hospitals, Healthcare and Social care across the world.”
HeiQ’s claims for its Viroblock treatment have been independently verified as effective to ISO 18184 and ISO 20743 standards by the world-renowned Peter Doherty Institute for Infection and Immunity based in Australia.
To see how HeiQ Viroblock works visit https://www.youtube.com/watch?v=aeXn1Up_qdE